Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.380
+0.110 (3.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Titan Pharmaceuticals Employees
Titan Pharmaceuticals had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$750
Profits / Employee
-$1,365,250
Market Cap
3.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ReShape Lifesciences | 29 |
ENDRA Life Sciences | 21 |
InMed Pharmaceuticals | 13 |
Entero Therapeutics | 9 |
SCWorx | 7 |
Artelo Biosciences | 6 |
Tharimmune | 3 |
Alaunos Therapeutics | 1 |
TTNP News
- 24 days ago - Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewsWire
- 4 months ago - TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP - Business Wire
- 4 months ago - Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. - GlobeNewsWire
- 11 months ago - Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets - GlobeNewsWire